Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 686,000 | 315,000 | 872,000 | 1,158,000 | 1,192,000 |
Receivables | 1,210,000 | 1,195,000 | 1,438,000 | 1,520,000 | 1,063,000 |
Inventories | 190,000 | 192,000 | 208,000 | 223,000 | 123,000 |
TOTAL | $2,372,000 | $1,898,000 | $2,741,000 | $3,058,000 | $2,490,000 |
Non-Current Assets | |||||
PPE Net | 1,816,000 | 1,766,000 | 1,707,000 | 1,627,000 | 1,453,000 |
Investments And Advances | 135,000 | 132,000 | 141,000 | 521,000 | 482,000 |
Intangibles | 8,899,000 | 8,312,000 | 8,262,000 | 8,040,000 | 7,740,000 |
Other Non-Current Assets | 800,000 | 729,000 | 760,000 | 780,000 | 678,000 |
TOTAL | $11,650,000 | $10,939,000 | $10,870,000 | $10,968,000 | $10,353,000 |
Total Assets | $14,022,000 | $12,837,000 | $13,611,000 | $14,026,000 | $12,843,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 303,000 | 2,000 | 2,000 | 2,000 | 804,000 |
Accounts payable and accrued liabilities | 1,359,000 | 1,396,000 | 1,600,000 | 1,633,000 | 1,041,000 |
TOTAL | $1,815,000 | $1,551,000 | $1,753,000 | $1,776,000 | $1,990,000 |
Non-Current Liabilities | |||||
Long Term Debt | 4,410,000 | 3,978,000 | 4,010,000 | 4,013,000 | 3,966,000 |
aiOther Non-Current Liabilities | 1,401,000 | 1,309,000 | 1,280,000 | 1,360,000 | 1,152,000 |
TOTAL | $5,865,000 | $5,356,000 | $5,375,000 | $5,441,000 | $5,166,000 |
Total Liabilities | $7,680,000 | $6,907,000 | $7,128,000 | $7,217,000 | $7,156,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 110,707 | 111,323 | 119,455 | 133,455 | 133,455 |
Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
Retained earnings | 8,825,000 | 8,290,000 | 7,649,000 | 9,303,000 | 8,174,000 |
Other shareholders' equity | 21,000 | 16,000 | 25,000 | 29,000 | 7,000 |
TOTAL | $6,342,000 | $5,930,000 | $6,483,000 | $6,809,000 | $5,687,000 |
Total Liabilities And Equity | $14,022,000 | $12,837,000 | $13,611,000 | $14,026,000 | $12,843,000 |